z-logo
open-access-imgOpen Access
Organophotoredox Hydrodefluorination of Trifluoromethylarenes with Translational Applicability to Drug Discovery
Author(s) -
Jeroen B. I. Sap,
Natan J. W. Straathof,
Thomas Knauber,
Claudio F. Meyer,
Maurice Médebielle,
Laura Buglioni,
Christophe Génicot,
Andrés A. Trabanco,
Timothy Noël,
Christopher W. am Ende,
Véronique Gouverneur
Publication year - 2020
Publication title -
journal of the american chemical society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.115
H-Index - 612
eISSN - 1520-5126
pISSN - 0002-7863
DOI - 10.1021/jacs.0c03881
Subject(s) - chemistry , combinatorial chemistry , hydrogen atom , molecule , drug discovery , fluorine , excited state , catalytic cycle , catalysis , photochemistry , atom (system on chip) , nanotechnology , stereochemistry , organic chemistry , biochemistry , alkyl , physics , computer science , nuclear physics , embedded system , materials science
Molecular editing such as insertion, deletion, and single atom exchange in highly functionalized compounds is an aspirational goal for all chemists. Here, we disclose a photoredox protocol for the replacement of a single fluorine atom with hydrogen in electron-deficient trifluoromethylarenes including complex drug molecules. A robustness screening experiment shows that this reductive defluorination tolerates a range of functional groups and heterocycles commonly found in bioactive molecules. Preliminary studies allude to a catalytic cycle whereby the excited state of the organophotocatalyst is reductively quenched by the hydrogen atom donor, and returned in its original oxidation state by the trifluoromethylarene.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom